Pulsenmore通过私募融资750万美元;股价下跌

2026-06-25 20:28

Pulsenmore (PLSM) entered into a private placement agreement with a healthcare-focused institutional investor.
The company will sell 1.56M ordinary shares (or pre-funded warrants in lieu thereof) along with warrants to purchase up to 1.56M additional shares.
The combined purchase price is $4.80/share and accompanying warrant, representing a premium to the Nasdaq minimum price requirement.
The financing is expected to generate ~$7.5M in gross proceeds before fees and expenses.
The accompanying warrants have an exercise price of $4.80 per share, are immediately exercisable, and expire five years after issuance.
The transaction is expected to close on or about June 26, 2026.
Proceeds will be used for marketing and commercialization efforts, working capital, and general corporate purposes.
PLSM shares down 12% premarket.

More on Pulsenmore Ltd.